Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

MLA

Bouquegneau, Antoine, et al. “Complement-Activating Donor-Specific Anti-HLA Antibodies and Solid Organ Transplant Survival: A Systematic Review and Meta-Analysis.” PLoS Medicine, vol. 15, no. 5, May 2018, p. e1002572. EBSCOhost, https://doi.org/10.1371/journal.pmed.1002572.

APA

Bouquegneau, A., Loheac, C., Aubert, O., Bouatou, Y., Viglietti, D., Empana, J.-P., Ulloa, C., Hassan Murad, M., Legendre, C., Glotz, D., Jackson, A. M., Zeevi, A., Schaub, S., Taupin, J.-L., Reed, E. F., Friedewald, J. J., Tyan, D. B., Süsal, C., Shapiro, R., & Woodle, E. S. (2018). Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. PLoS Medicine, 15(5), e1002572. https://doi.org/10.1371/journal.pmed.1002572

Chicago

Bouquegneau, Antoine, Charlotte Loheac, Olivier Aubert, Yassine Bouatou, Denis Viglietti, Jean-Philippe Empana, Camilo Ulloa, et al. 2018. “Complement-Activating Donor-Specific Anti-HLA Antibodies and Solid Organ Transplant Survival: A Systematic Review and Meta-Analysis.” PLoS Medicine 15 (5): e1002572. doi:10.1371/journal.pmed.1002572.